First do no harm: promoting an evidence-based approach to atypical antipsychotic use in children and adolescents.

Abstract

There is an urgent need for national clinical practice guidelines that provide, not only appropriate treatment algorithms for AAP-use based on evidence, but also address metabolic monitoring and subsequent management of complications in this vulnerable population.